Diamedica Therapeutics (DMAC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Diamedica Therapeutics Inc. has filed a current report with the SEC, indicating a significant event or update as of May 22, 2024. The company’s voting common shares are listed on The Nasdaq Stock Market under the ticker symbol DMAC. This report reflects the company’s continuous compliance with the regulatory requirements of the Securities Exchange Act of 1934.
For further insights into DMAC stock, check out TipRanks’ Stock Analysis page.